EN DE

BlackRock Science and Technology Term Trust (BSTZ) Fair Value & Analysis

Financial Services · US · Market cap $2.1B

BS BlackRock Science and Technology Term Trust logo BlackRock Science and Technology Term Trust BSTZ · US
Price$30.08
Fair Value$29.72
Upside-1.2%
Quality40/100
Watch BlackRock Science and Technology Term Trust for free, get notified when fair value or trend changes. Watch for free
Weak Growth
Thin margins · 0.0% net margin
negative free cash flow
Trails peers (2/11)
Moderate moat 58/100
Evidence: High Range $22.30 – $37.15 Share as image

Fair value as of: Jul 26, 2026

From 8 valuation models · updated 15 days ago

Share price +5.1% over the past month.

Below-average quality, currently priced close to our fair value.

What matters now

  • The price sits close to our fair value, market and models broadly agree here, little valuation tension.
  • For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

$31.68 $10.44 Fair Value $29.72 Apr 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 26, 2026.

How to read this chart

60‑month range $10.44 – $31.68 · fair‑value band $22.30 – $37.15 · the $30.08 price screens above the $29.72 fair value. Dashed = 300-day average. As of Jul 26, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

BlackRock Science and Technology Term Trust (BSTZ) currently trades at $30.08, while our model-based Fair Value estimate is $29.72, implying the stock looks roughly 1.2% fairly valued today. The Quality Score stands at 40/100 (below-average quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Net debt stands at $16.8M. The stock trades on a trailing P/E of 6.5. Fundamentals as of Jul 26, 2026

Our scenario range runs from $22.30 (bear case) to $37.15 (bull case); at $30.08, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 6% below its 52-week high and 73% above its 52-week low, currently above its 200-day average. For context, the median of 10 Financial Services peers we cover trades at -12% fair-value upside, at -1%, BSTZ screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model BearBaseBull Evidence
Highest evidence
Residual Income $28.82 $36.92 $109.37 76
Gordon GGM $19.60 $39.05 $59.13 70
P/E Multiple $44.59 $59.45 $74.31 63
All 8 models by family
Earnings-Based
Graham-Dodd $31.10 $216.86 $304.33 54
Lynch FV $112.04 $160.05 $208.07 50
Dividend Discount
Gordon GGM $19.60 $39.05 $59.13 70
DDM Multi-Stage $19.60 $33.75 $41.22 61
Multiples
P/E Multiple $44.59 $59.45 $74.31 63
P/B Multiple $26.23 $34.97 $43.71 55
Asset-Based
NCAV (Graham) $12.49 $16.74 $24.98 50
Economic Profit
Residual Income $28.82 $36.92 $109.37 76

Widest divergence: Earnings-Based ($160.05) versus Asset-Based ($16.74). Highest evidence: Residual Income (76).

Key figures & financial health

Free cash flow −$47.8M FY2025
P/E ratio 6.5
EPS (TTM) $4.65
Net debt $16.8M FY2025

Figures from reported company fundamentals · as of Jul 26, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 40/100

Of which business quality 37 · Market factors (momentum, volatility) 81

Profitability 58
Margins and returns on capital today
Quality Growth 44
Are margins and returns improving?
Cashflow 0
Earnings quality: real cash, not paper profit
Fin. Strength 75
Balance sheet, leverage, solvency risk
Investment 33
Disciplined investing over empire-building
Low Volatility 71
Calm price path (market factor)
Momentum 82
Price trend over the last 3–12 months (market factor)
52W Momentum 92
Distance to the 52-week high (market factor)
Net Issuance 0
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

BlackRock Science and Technology Term Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating in the science and technology sectors.

Full company description

BlackRock Science and Technology Term Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating in the science and technology sectors. It primarily invests in growth stocks of companies across all market capitalizations. BlackRock Science and Technology Term Trust was formed in June 2019 and is domiciled in the United States.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

BlackRock Science and Technology Term Trust reported revenue of $266M in FY2025 versus $251M in FY2021, a compound +1.5%/yr. Reported net income was $314M in FY2025, compounding +6.0%/yr from FY2021.

Growth Quality 3/100
Revenue growth is weak, negative or inconsistent.
Latest Revenue (FY 2025)
$266M
Latest YoY
−3.0%
Avg. growth/yr (5Y)
−29.1%
Avg. growth/yr (6Y)
+15.2%
Revenue +1.5%/yr
FY21 $251M
FY22 −$1.3B
FY23 −$34.3M
FY24 $274M
FY25 $266M
Net income +6.0%/yr
FY21 $249M
FY22 −$1.3B
FY23 $290M
FY24 $272M
FY25 $314M

Watch BSTZ: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "BlackRock Science and Technology Term Trust Fair Value". https://www.fairvalue-calculator.com/stock/BSTZ

Peer Group

Asset Management · 973 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 39 · Bottom 25%
Fair Value upside −1% · Below median
Return on assets 0% · Below median
Net margin (TTM) 0% · Below median
Operating margin (TTM) 0% · Bottom 25%
Revenue growth 0% · Below median
Dividend yield (TTM) 0.0% · Bottom 25%

Valuation Multiples vs Asset Management median · lower = cheaper

P/E (TTM) 6.5× · Cheaper than median
P/B 1.21× · Pricier than median
EV/EBITDA 6.6× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 32 · sector 37
FUTURE 0 · sector 6
PAST 0 · sector 26
HEALTH 0 · sector 95
DIVIDEND 0 · sector 69

Insider activity: 78/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Asset Management stocks, each showing price versus our Fair Value estimate (as of Jul 26, 2026).

Stock Price Fair Value vs Fair Value
Fondul Proprietatea SA FP $0.0420 $0.0800 +90%
BlackRock, Inc BLK $1,136 $465.75 -59%
Blackstone Inc BX $124.56 $16.35 -87%
Investor AB INVEB kr 423.70 kr 847.40 +100%
Brookfield Corporation BN C$62.45 C$10.12 -84%
KKR & Co KKR $100.94 $44.88 -56%
AB Industrivärden INDUA kr 532.50 kr 1,065 +100%
Jio Financial Services Limited JIOFIN ₹242.98 ₹40.19 -83%
Hedef Holding HEDEF 267.25 TRY 320.98 TRY +20%
Bajaj Holdings BAJAJHLDNG ₹10,398 ₹9,202 -12%

Compare BlackRock Science and Technology Term Trust with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is BlackRock Science and Technology Term Trust (BSTZ) overvalued or undervalued?
As of Jul 26, 2026, our model estimates a fair value of $29.72 versus a price of $30.08, about −1% (fairly valued).
What is the fair value of BSTZ?
Our model-based fair value for BlackRock Science and Technology Term Trust is $29.72 (as of Jul 26, 2026), built from audited fundamentals. The current price is $30.08.
What is the quality score of BSTZ?
BlackRock Science and Technology Term Trust has a Quality Score of 40/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the net profit margin of BSTZ?
The net profit margin of BlackRock Science and Technology Term Trust is about 0.0%, meaning it keeps roughly 0.0% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track BlackRock Science and Technology Term Trust and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.